Here's What We Know: A Vigorous Screening Program and an Array of Innovative Treatments Benefit Lung Cancer Patients

On October 13, Pope Leo was diagnosed with the most common type of lung cancer, called adenocarcinoma. Surgeons removed the lower lobe of the pontiff’s right lung, where a localized tumor was lodged, and he has since been declared cancer-free.

That very welcome scenario would have been unlikely a few short years ago, says Dr. Christine Garcia, a medical oncologist and assistant professor of medicine at Weill Cornell Medicine.

Keep reading for an overview of lung cancer: its two broad types and its symptoms and risk factors, along with the innovative treatments that are transforming patients’ lives and their prospects for recovery.

The big picture

Lung cancer is the leading cause of cancer death in the United States. The disease comes in two major forms: small-cell and non-small-cell.

  • Small-cell lung cancer accounts for 15 to 20 percent of cases. It’s strongly associated with cigarette smoking, and it’s generally more aggressive than non-small-cell lung cancer.
  • Non-small-cell lung cancer is far more prevalent, with adenocarcinoma its most common subtype.

The disease develops when cells in the lungs start growing uncontrollably, eventually forming tumors. DNA damage often drives the process.

Risk factors

The biggest risk factor of all is cigarette smoking, which is linked to 80 to 90 percent of lung cancer deaths.

Surprisingly, though, a growing number of “never smokers” are being diagnosed with lung cancer. “These patients are often younger, female and of Asian descent,” says Dr. Garcia. “Research is underway to determine why that’s the case.”

Additional risk factors include:

  • older age
  • exposure to radon, secondhand smoke, environmental pollution or other airborne toxins
  • family history

Symptoms

At an early stage, lung cancer symptoms can be mild and non-specific, such as a persistent cough, fatigue and shortness of breath. These could be symptoms of a variety of other diseases and conditions, which is why early detection can be so challenging.

But at later stages, its symptoms are unmistakable. If, in addition to the symptoms described above, you’re coughing up blood and experiencing unintended weight loss, make an appointment with their primary doctor or visit an emergency room.

Innovative treatments

Single-port surgery

Instead of making multiple incisions to remove an early-stage, discrete lung tumor, thoracic surgeons at Weill Cornell Medicine have pioneered a procedure called single-port robotic surgery. It’s performed under the rib cage, which allows patients to avoid the post-operative nerve pain associated with the traditional, multi-port method. They generally need only half of the pain medication compared to those undergoing the multi-port procedure, and they tend to recover faster as well.

Pope Leo underwent single-port surgery, and by all accounts, he is doing extremely well, requiring no further treatment for the foreseeable future.

Targeted therapy

“We’re always asking what a patient’s cancer is doing at the molecular level, and what the right treatment is, based on that patient’s specific cancer mutations,” Dr. Garcia says. Rather than administering traditional chemotherapy—a one-size-fits-all approach—physicians can tailor treatment to the specific genetic features of a patient’s cancer. Treatment can even come in the form of a daily pill.

Immunotherapy

However, many patients lack a mutation-specific biomarker that can be targeted therapeutically. For them, immunotherapy can be an excellent option. The idea is to activate a patient’s immune system, teaching it to kill cancer cells.

Dr. Jonathan Villena-Vargas, an assistant professor of clinical cardiothoracic surgery at Weill Cornell Medicine, explains what happens when immunotherapy is given before the cancer is surgically removed. “When immunotherapy is given before surgery, the tumor and its surrounding lymph nodes stay intact. By exposing the immune system to the tumor while it is still in the body, there may be a stronger immune response—one that continues to recognize cancer cells even after the tumor has been removed,” decreasing the likelihood of a recurrence.

A team-based approach

Every week, a team of specialists meets to discuss the treatments individual patients are receiving and how each one is faring. The lung cancer team is composed of the following specialists:

  • medical oncologists
  • surgeons
  • radiation oncologists
  • radiologists
  • pulmonologists
  • pathologists

Says Dr. Garcia, “at least a dozen people are reviewing each individual patient” on a weekly basis.

In addition, a wide array of treatment options available at Weill Cornell Medicine, and the quality of care patients receive, the institution’s team-based approach is a key aspect of the outstanding cancer care provided by the hospitals and clinical practices that live under the Weill Cornell umbrella.

Lung cancer screening: Who is eligible?

If you’re considered at increased risk for lung cancer, you’re probably eligible for low-dose CT screening.

The U.S. Preventive Services Task Force (USPSTF) recommends annual screening for people who meet certain criteria. Seek screening if you are:

  • 50 to 80 years old
  • a current or former smoker who quit within the last 15 years
  • free from any signs or symptoms of lung cancer

However, says Dr. Garcia, the American Cancer Society (ACS) dropped the “quit year” requirement, making it easier to get screened.

You can come in for a consultation and choose to participate in Weill Cornell’s low-dose CT screening program. Alternatively, a mobile van, equipped with a CT scanner, radiologist and nurse practitioner, may be coming to your neighborhood soon.

A low-dose CT scan can detect the disease at its earliest stages. The problem is that only 19 percent of eligible New Yorkers undergo recommended screenings.

The mobile unit promises to increase that number by eliminating barriers to care, such as geographical location and the sheer complexity of navigating the healthcare system.

The program will also provide patients with tobacco cessation support and referrals for treatment, if needed.

“We’re taking the scanner to the streets,” says Dr. Bradley Pua, an associate professor of radiology and chief of interventional radiology at Weill Cornell Medicine. A ribbon-cutting ceremony took place on October 17 to formally mark the van’s launch.

Screenings and consultations are fully covered by commercial insurance, Medicare and Medicaid.

To schedule a telehealth consultation, call 646-962-LUNG (5864), or visit GetCheckedNY.org to see a list of upcoming mobile van locations.

Key takeaway points

  • Pope Leo was recently diagnosed and successfully treated for lung adenocarcinoma, the most common type of lung cancer.
  • Doctors can successfully treat that type of cancer with minimally invasive surgery when it is caught early.
  • Early-stage symptoms may include a persistent cough, fatigue and shortness of breath.
  • At a later stage, the disease can cause a person to cough up blood and involuntarily lose weight.
  • Risk factors include older age, smoking, environmental exposures and a family history of lung cancer.
  • Advances in treatment, including immunotherapies and drugs that target specific mutations, have helped to reduce the likelihood of recurrence and improved the prognosis for later-stage lung cancers.
  • A multidisciplinary, team-based approach means that 12 specialists review each patient’s progress on a weekly basis.
  • You’re eligible for low-dose CT screening at the hospital or radiology facility, or in Weill Cornell’s new mobile van if you’re between 50 and 80 years old with a significant history of smoking and are currently symptom-free

In This Article